chevron_leftBack
As of 24 April 2025, NEXGEL, Inc. has a market cap of $20.67M USD, ranking #29672 globally and #4353 in the United States. It ranks #2970 in the Healthcare sector, and #212 in the Medical Instruments & Supplies industry.
Key Stats
Market Cap
$20.67MUSD
Enterprise Value
$21.68MUSD
Revenue (TTM)
$8.69MUSD
EBITDA (TTM)
-$3.12MUSD
Net Income (TTM)
-$3.28MUSD
EBITDA Margin
-36%
Profit Margin
-38%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Adam Levy
open_in_new
Employees
19
Founded
1997
IPO
22 Dec 2021
Website
nexgel.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.4% | -2.8% | 1.9% | -16% | -8.4% | 26% |
Upcoming Earnings
Earnings Date
Mon, May 12
Earnings Time
bedtime
After Close
EPS Estimate
-$0.1000
Revenue Estimate
$2.73M
116% yoy
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
NXGL
NexGel Inc
ISIN: US65344E1073
Shares Out.:
Shares Outstanding:
7.654M1
Shares Float:
6.139M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
2.75 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About NEXGEL, Inc.
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.
